| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.21 | 4e-05 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |